Comparable potency of IFNα2 and IFNß on immediate JAK/STAT activation but differential down-regulation of IFNAR2
Comparable potency of IFNα2 and IFNß on immediate JAK/STAT activation but differential down-regulation of IFNAR2
复制标题
DOI:
10.1042/bj20070605
复制
发表时间:
2007-10-01
影响因子:
4.1
通讯作者:
Pellegrini, Sandra
中科院分区:
文献类型:
--
作者:
Marijanovic, Zrinka;Ragimbeau, Josiane;Pellegrini, Sandra
Type I IFNs (interferons) (IFN alpha/beta) form a family of related cytokines that control a variety of cellular functions through binding to a receptor composed of IFNAR (IFN alpha receptor subunit) 1 and 2. Among type I IFNs, the alpha 2 and beta subtypes exhibit a large difference in their binding affinities to IFNAR1, and it was suggested that high concentrations of IFNAR1 may compensate for its low intrinsic binding affinity for IFN alpha 2. We tested whether receptor-proximal signalling events are sensitive to IFNAR1 surface concentration by investigating the relationship between relative IFNAR1/IFNAR2 surface levels and IFN alpha 2 and IFN beta signalling potencies in several cell lines. For this, we monitored the activation profile of JAK (Janus kinase)/STAT (signal transducer and activator of transcription) proteins, measured basal and ligand-induced surface decay of each receptor subunit and tested the effect of variable IFNAR1 levels on IFNa2 signalling potency. Our data show that the cell-surface IFNAR1 level is indeed a limiting factor for assembly of the functional complex, but an increased concentration of it does not translate into an IFN alpha/beta differential JAK/STAT signalling nor does it change the dynamics of the engaged receptor. Importantly, however, our data highlight a differential effect upon routing of IFNAR2. Following binding of IFN alpha 2, IFNAR2 is internalized, but, instead of being routed towards degradation as it is when complexed to IFN, it recycles back to the cell surface. These observations suggest strongly that the stability and the intracellular lifetime of the ternary complex account for the differential control of IFNAR2. Moreover, the present study opens up the attractive possibility that endosomal-initiated signalling may contribute to IFN alpha/beta differential bioactivities.